Facebook tracking pixel
S10.AI
ICD-10-CM · M16.9GeneralSystemic

Degenerative Joint Disease of the Hip

Understand Degenerative Joint Disease of the Hip (DJD Hip), also known as Hip Osteoarthritis or OA of the Hip. This resource provides information on diagnosis, clinical documentation, and medical coding for DJD Hip, supporting healthcare professionals in accurate reporting and patient care. Learn about symptoms, treatment options, and ICD-10 codes related to Degenerative Joint Disease and Hip Osteoarthritis.

Also known as
DJD HipHip OsteoarthritisOA of the Hip
Definition

Progressive cartilage loss in the hip joint causing pain and stiffness.

Clinical signs

Groin pain, limited range of motion, stiffness, creaking or grinding sensation.

Common settings

Primary care, orthopedics, physical therapy, pain management clinics.

Related Codes

ICD-10 Code Families

Complete code families applicable to M16.9

M16.-
Coxarthrosis
M15.-
Polyarthrosis
M19.-
Other arthrosis
Code Comparison

When to use each related code

DescriptionWhen to use
Hip joint wear and tear causing pain and stiffness.Use for chronic hip pain and stiffness with radiological evidence of osteoarthritis. Consider age and activity level.
Inflammation of the hip joint lining, causing pain and limited movement.Use for acute or chronic hip pain, swelling, warmth, and limited range of motion. May be infectious or non-infectious.
Avascular necrosis of the femoral head disrupting blood supply.Use for hip pain, particularly with history of steroid use, trauma, or other risk factors. Imaging confirms diagnosis.
Documentation

Best-practice checklist

  • ✓Document laterality (left, right, bilateral)
  • ✓Specify joint location (e.g., head, neck, acetabulum)
  • ✓Grade OA severity (e.g., Kellgren-Lawrence)
  • ✓Note symptom duration and characteristics
  • ✓Document impact on ADLs and mobility
Coding & Audit Risks

Common pitfalls to avoid

Laterality Coding

Missing or unspecified laterality (right, left, bilateral) can lead to claim denials and inaccurate data reporting for DJD Hip.

Specificity of DJD Hip

Coding to the appropriate level of specificity, including primary vs. secondary OA and anatomical site within the hip, is crucial for accurate reimbursement.

Underlying Cause

Documenting and coding any underlying cause of the degenerative joint disease, such as trauma or other conditions, can impact severity and treatment.

Mitigation

Best-practice tips

  • 01Code accurately: M16 ICD-10, 715.15, 715.35 ICD-9
  • 02Document symptom onset, severity, and impact on ADLs
  • 03Assess pain using validated scales (e.g., VAS, WOMAC)
  • 04Note radiographic findings (e.g., joint space narrowing)
  • 05Document non-pharmacological and pharmacological treatments
Clinical Decision Support

Step-by-step checklist

  1. 1

    Verify hip pain impacting mobility (ICD-10: M16.-)

  2. 2

    Assess ROM limitation and crepitus on exam

  3. 3

    Review imaging for joint space narrowing, osteophytes

  4. 4

    Exclude other hip pathologies (e.g., fracture, infection)

  5. 5

    Document symptom duration and severity for accurate coding

Documentation Template

Ready-to-paste narrative

Patient presents with complaints consistent with degenerative joint disease of the hip, also known as hip osteoarthritis or DJD hip.  Symptoms include progressively worsening anterior hip pain, stiffness, and limited range of motion, exacerbated by weight-bearing activities and relieved by rest.  Onset of symptoms has been gradual over the past six months.  The patient reports difficulty with activities of daily living such as walking, dressing, and rising from a seated position.  Physical examination reveals decreased hip flexion, internal rotation, and abduction.  Palpation elicits tenderness over the anterior hip joint.  Crepitus is noted with passive range of motion.  Radiographic imaging of the affected hip demonstrates joint space narrowing, osteophyte formation, and subchondral sclerosis, confirming the diagnosis of hip osteoarthritis.  Differential diagnosis includes avascular necrosis, labral tear, and trochanteric bursitis.  The patient's symptoms are attributed to the degenerative changes in the hip joint cartilage.  Treatment plan includes conservative management with NSAIDs for pain relief, physical therapy to improve range of motion and strengthen supporting musculature, and weight management counseling.  Patient education regarding the disease process and activity modification was provided.  Follow-up appointment scheduled in four weeks to assess response to treatment and consider intra-articular corticosteroid injection if symptoms persist.  ICD-10 code M16.  Medical necessity for ongoing treatment will be reevaluated at each visit.
FAQs

Common questions and answers

What are the most effective non-surgical interventions for managing pain and improving function in patients with degenerative joint disease of the hip (DJD Hip)?+

Non-surgical management of DJD hip, also known as hip osteoarthritis, aims to reduce pain, improve function, and slow disease progression. Evidence-based interventions include: 1) Weight management: Even modest weight loss can significantly reduce joint loading and pain. Explore how patient education and support can facilitate successful weight loss. 2) Exercise therapy: A structured program incorporating strengthening, range-of-motion, and low-impact aerobic exercises is crucial. Consider implementing individualized exercise prescriptions tailored to the patient's abilities and preferences. 3) Pharmacologic management: Analgesics like acetaminophen, NSAIDs (with gastrointestinal protection), and topical agents can offer pain relief. Intra-articular corticosteroid injections can provide temporary relief for moderate to severe pain. Learn more about current guidelines for the safe and effective use of these medications in DJD hip management.

How can clinicians differentiate between degenerative joint disease of the hip (hip OA) and other causes of hip pain, such as labral tears or femoroacetabular impingement (FAI), during physical examination?+

Differentiating hip OA from other hip pathologies like labral tears or FAI requires a thorough history and targeted physical exam. While hip OA typically presents with gradual onset groin pain radiating to the buttock, thigh, or knee, often worsened by weight-bearing activities and relieved by rest, FAI and labral tears may present with sharp, clicking, or catching sensations. Specific exam maneuvers, like the FADIR and FABER tests, can assess for FAI, while assessing internal and external rotation range of motion and reproducing groin pain can suggest a labral tear. Consider incorporating dynamic ultrasound examination to further evaluate soft tissue structures and aid in accurate diagnosis. Explore how advanced imaging techniques like MRI can provide detailed information for complex cases.

When is total hip arthroplasty (THA) indicated for patients with degenerative joint disease of the hip, and what factors influence the decision-making process?+

THA is generally considered when non-surgical interventions fail to provide adequate pain relief and functional improvement for patients with advanced DJD hip. The decision for THA is made on a case-by-case basis, considering the patient's age, overall health, activity level, and the severity of their symptoms. Persistent pain impacting quality of life, significant limitations in daily activities, and radiographic evidence of advanced joint damage are key indicators. Learn more about the latest advancements in THA techniques and the importance of shared decision-making with patients when considering surgical intervention. Consider implementing standardized pre-operative assessment protocols to optimize patient selection and improve post-surgical outcomes.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.